Back
Athira Pharma 10K Form
Sell
43
ATHA
Athira Pharma
Last Price:
2.54
Seasonality Move:
-40.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATHA News And Ratings
See the #1 stock for the next 7 days that we like better than ATHA
ATHA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-25.81M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.79 |
| Price / Book: | 0.91 |
Profitability
| EPS (TTM): | -3.05000 |
|---|---|
| Net Income (TTM): | $-116.19M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Athira Pharma Earnings Forecast
Key Athira Pharma Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 2 years.
Athira Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ATHA |
| CUSIP: | 04746L |
| Website: | athira.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATHA Technical Analysis vs Fundamental Analysis
Sell
43
Athira Pharma (ATHA)
is a Sell
Is Athira Pharma a Buy or a Sell?
-
Athira Pharma stock is rated a Sell
The current Athira Pharma [ATHA] share price is $2.53. The Score for ATHA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.